Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.
Caraglia M, Addeo R, Costanzo R, Montella L, Faiola V, Marra M, Abbruzzese A, Palmieri G, Budillon A, Grillone F, Venuta S, Tagliaferri P, Del Prete S. Caraglia M, et al. Among authors: abbruzzese a. Cancer Chemother Pharmacol. 2006 Jan;57(1):34-9. doi: 10.1007/s00280-005-0001-z. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16010592 Clinical Trial.
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.
Addeo R, Caraglia M, Bellini S, Abbruzzese A, Vincenzi B, Montella L, Miragliuolo A, Guarrasi R, Lanna M, Cennamo G, Faiola V, Del Prete S. Addeo R, et al. Among authors: abbruzzese a. J Clin Oncol. 2010 Feb 1;28(4):543-8. doi: 10.1200/JCO.2008.20.8199. Epub 2009 Oct 19. J Clin Oncol. 2010. PMID: 19841330 Clinical Trial.
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.
Addeo R, Caraglia M, De Santi MS, Montella L, Abbruzzese A, Parlato C, Vincenzi B, Carraturo M, Faiola V, Genovese M, Cennamo G, Del Prete S. Addeo R, et al. Among authors: abbruzzese a. J Neurooncol. 2011 May;102(3):417-24. doi: 10.1007/s11060-010-0329-z. Epub 2010 Aug 10. J Neurooncol. 2011. PMID: 20694830 Free PMC article. Clinical Trial.
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients.
Correale P, Botta C, Basile A, Pagliuchi M, Licchetta A, Martellucci I, Bestoso E, Apollinari S, Addeo R, Misso G, Romano O, Abbruzzese A, Lamberti M, Luzzi L, Gotti G, Rotundo MS, Caraglia M, Tagliaferri P. Correale P, et al. Among authors: abbruzzese a. Cancer Biol Ther. 2011 Jul 15;12(2):112-8. doi: 10.4161/cbt.12.2.15722. Epub 2011 Jul 15. Cancer Biol Ther. 2011. PMID: 21525780 Free article. Clinical Trial.
MUC2: a new key for pancreas cancer prognosis.
Addeo R, Abbruzzese A, Del Prete S. Addeo R, et al. Among authors: abbruzzese a. Cancer Biol Ther. 2009 Jun;8(11):1000-1. doi: 10.4161/cbt.8.11.8703. Cancer Biol Ther. 2009. PMID: 19587529 Free article. No abstract available.
180 results